Compare HMN & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HMN | PLSE |
|---|---|---|
| Founded | 1945 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 1996 | 2015 |
| Metric | HMN | PLSE |
|---|---|---|
| Price | $43.45 | $18.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $47.33 | $22.00 |
| AVG Volume (30 Days) | 220.9K | ★ 497.9K |
| Earning Date | 05-01-2026 | 06-01-2026 |
| Dividend Yield | ★ 3.22% | N/A |
| EPS Growth | ★ 127.52 | N/A |
| EPS | ★ 3.03 | N/A |
| Revenue | ★ $1,595,200,000.00 | N/A |
| Revenue This Year | $7.56 | $883.71 |
| Revenue Next Year | $4.64 | $225.88 |
| P/E Ratio | $14.39 | ★ N/A |
| Revenue Growth | ★ 6.92 | N/A |
| 52 Week Low | $38.76 | $12.56 |
| 52 Week High | $48.33 | $26.30 |
| Indicator | HMN | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 50.79 | 48.06 |
| Support Level | $43.47 | $13.75 |
| Resistance Level | $44.25 | $18.93 |
| Average True Range (ATR) | 0.98 | 2.08 |
| MACD | 0.11 | -0.65 |
| Stochastic Oscillator | 70.47 | 1.80 |
Horace Mann Educators Corp is a diversified insurance holding company that markets and underwrites personal lines of property and casualty insurance, retirement annuities, and life insurance. The company's property and casualty operations focus on automobile and homeowner insurance, while the retirement annuities are 403(b) tax-qualified products. Horace Mann Educators markets its products to kindergarten through 12th-grade teachers, administrators, and other employees of public schools and their families. The Company conducts and manages its business in four reporting segments: (1) Property & Casualty, (2) Life & Retirement, (3) Supplemental & Group Benefits and (4) Corporate & Other.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.